Future treatment of gonorrhea--novel emerging drugs are essential and in progress?
作者信息
Unemo Magnus, Shafer William M
机构信息
a 1 Örebro University, Örebro, National Reference Laboratory for Pathogenic Neisseria, WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health , Örebro, Sweden +46 19 602 2038 ; +46 19 127 416 ;
出版信息
Expert Opin Emerg Drugs. 2015 Sep;20(3):357-60. doi: 10.1517/14728214.2015.1039981. Epub 2015 Jul 3.
Abstract
摘要
相似文献
1
Future treatment of gonorrhea--novel emerging drugs are essential and in progress?淋病的未来治疗——新型药物至关重要且正在研发中？
Expert Opin Emerg Drugs. 2015 Sep;20(3):357-60. doi: 10.1517/14728214.2015.1039981. Epub 2015 Jul 3.
2
Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.淋病奈瑟菌的抗菌敏感性：一项来自科威特的基于医院的研究。
J Chemother. 2005 Feb;17(1):117-8. doi: 10.1179/joc.2005.17.1.117.
3
The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.多重耐药和无法治疗的淋病的严重威胁：全球采取行动控制抗菌药物耐药性传播并减轻对性与生殖健康影响的迫切需求。
Sex Transm Infect. 2012 Aug;88(5):317-8. doi: 10.1136/sextrans-2012-050674.
4
Prospects of untreatable gonorrhea and ways forward.无法治愈的淋病前景及未来方向。
Future Microbiol. 2015;10(3):313-6. doi: 10.2217/fmb.14.138.
5
6
Drug-resistant Neisseria gonorrhoeae: latest developments.耐多药淋病奈瑟菌：最新进展
Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1065-1071. doi: 10.1007/s10096-017-2931-x. Epub 2017 Feb 16.
7
Antimicrobial susceptibility and genotypic distribution of Neisseria gonorrhoeae: a 2-year study in Tunisia.淋病奈瑟菌的抗菌药物敏感性及基因型分布：突尼斯的一项为期两年的研究。
Med Mal Infect. 2013 May;43(5):211-2. doi: 10.1016/j.medmal.2013.02.001. Epub 2013 Apr 25.
8
Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.支持用环丙沙星对淋病进行个体化治疗的进一步证据。
Lancet Infect Dis. 2016 Sep;16(9):1005-1006. doi: 10.1016/S1473-3099(16)30271-7.
9
Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?延缓头孢菌素耐药淋病的广泛出现：最佳靶点是什么？
Sex Transm Infect. 2015 Jun;91(4):232-3. doi: 10.1136/sextrans-2015-052009.
10
Gonococcal antimicrobial resistance.淋球菌抗菌药物耐药性。
Indian J Med Microbiol. 2015 Jul-Sep;33(3):341-2. doi: 10.4103/0255-0857.158531.
引用本文的文献
1
Sexually Transmitted Infections Treatment Guidelines, 2021.《2021年性传播感染治疗指南》
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
2
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.基于 B 群脑膜炎奈瑟菌外膜囊泡的疫苗 4CMenB 可诱导针对淋病奈瑟菌的种间保护。
PLoS Pathog. 2020 Dec 8;16(12):e1008602. doi: 10.1371/journal.ppat.1008602. eCollection 2020 Dec.
3
Identification and Characterization of the Neisseria gonorrhoeae MscS-Like Mechanosensitive Channel.鉴定和表征淋病奈瑟菌 MscS 样机械敏感通道。
Infect Immun. 2018 May 22;86(6). doi: 10.1128/IAI.00090-18. Print 2018 Jun.
4
Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.淋病奈瑟菌的抗菌药物耐药性：一种新出现的全球威胁的历史、分子机制及流行病学方面
Braz J Microbiol. 2017 Oct-Dec;48(4):617-628. doi: 10.1016/j.bjm.2017.06.001. Epub 2017 Jul 12.
5
Gonorrhea - an evolving disease of the new millennium.淋病——新千年不断演变的疾病。
Microb Cell. 2016 Sep 5;3(9):371-389. doi: 10.15698/mic2016.09.524.
6
Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil.对头孢克肟敏感性降低但对头孢曲松不降低：巴西淋病治疗的一个不确定前景。
Int J Antimicrob Agents. 2017 Apr;49(4):515-516. doi: 10.1016/j.ijantimicag.2017.02.003. Epub 2017 Feb 21.
7
Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.淋病的当前及未来抗菌治疗——不断快速演变的淋病奈瑟菌持续构成挑战。
BMC Infect Dis. 2015 Aug 21;15:364. doi: 10.1186/s12879-015-1029-2.
本文引用的文献
1
In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.磷霉素单独及与头孢曲松或阿奇霉素联合对临床淋病奈瑟菌分离株的体外活性
Antimicrob Agents Chemother. 2015 Mar;59(3):1605-11. doi: 10.1128/AAC.04536-14. Epub 2014 Dec 29.
2
In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.新型双环内酯类药物莫昔克丁（EDP-420、EP-013420、S-013420）和 EDP-322 对耐多药临床淋病奈瑟菌分离株和国际参考菌株的体外活性。
J Antimicrob Chemother. 2015 Jan;70(1):173-7. doi: 10.1093/jac/dku344. Epub 2014 Sep 1.
3
Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic.包含补体因子H结构域6和7以及人IgG1 Fc的融合蛋白作为一种抗菌免疫疗法。
Clin Vaccine Immunol. 2014 Oct;21(10):1452-9. doi: 10.1128/CVI.00444-14. Epub 2014 Aug 20.
4
The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.庆大霉素联合阿奇霉素以及吉米沙星联合阿奇霉素治疗单纯性淋病的疗效与安全性。
Clin Infect Dis. 2014 Oct 15;59(8):1083-91. doi: 10.1093/cid/ciu521. Epub 2014 Jul 16.
5
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.21世纪淋病奈瑟菌的抗菌药物耐药性：过去、演变及未来
Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14.
6
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.新型螺旋嘧啶三酮类DNA促旋酶抑制剂AZD0914对多重耐药淋病奈瑟菌分离株具有较高的体外活性，这为淋病的口服治疗提供了一种新的有效选择。
Antimicrob Agents Chemother. 2014 Sep;58(9):5585-8. doi: 10.1128/AAC.03090-14. Epub 2014 Jun 30.
7
Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.分子方法增强淋球菌抗菌药物耐药性监测。
Nat Rev Microbiol. 2014 Mar;12(3):223-9. doi: 10.1038/nrmicro3217. Epub 2014 Feb 10.
8
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.2012年成人淋病诊断与治疗欧洲指南。
Int J STD AIDS. 2013 Feb;24(2):85-92. doi: 10.1177/0956462412472837.
9
Current and future treatment options for gonorrhoea.淋病的当前和未来治疗选择。
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv52-6. doi: 10.1136/sextrans-2012-050913. Epub 2013 Oct 8.
10
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.出现了耐多药、广泛耐药和无法治疗的淋病。
Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117.
Zotero 插件